{"entity":{"type":"insider","cik":"0001450485","url":"/insider/0001450485","json_url":"/insider/0001450485.json","name":"Lurker Nancy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":14,"first":"2009-08-18","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Lurker Nancy","source":"filing","n_filings":14,"first_seen":"2009-08-18","last_seen":"2026-05-15"}],"transactions":[{"id":6211402,"accession":"0001450485-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450485-26-000007","line_url":"/filing/0001450485-26-000007#line-1","is_derivative":false,"issuer_cik":"0001267565","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001267565","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":35.9691,"price_display":"35.97","price_state":"stated","total_value":161860.95,"total_display":"161,860.95","total_whole":"161,861","shares_owned_after":18017.0,"shares_owned_after_display":"18,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-15","scope":"insider"},{"id":4513325,"accession":"0001450485-25-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450485-25-000009","line_url":"/filing/0001450485-25-000009#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9300.0,"shares_display":"9,300","price_per_share":15.1051,"price_display":"15.11","price_state":"stated","total_value":140477.43,"total_display":"140,477.43","total_whole":"140,477","shares_owned_after":206547.0,"shares_owned_after_display":"206,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-05","scope":"insider"},{"id":4362932,"accession":"0001450485-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001450485-25-000007","line_url":"/filing/0001450485-25-000007#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":7475.0,"total_display":"7,475.00","total_whole":"7,475","shares_owned_after":215847.0,"shares_owned_after_display":"215,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-01","scope":"insider"},{"id":4362928,"accession":"0001450485-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450485-25-000007","line_url":"/filing/0001450485-25-000007#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":2990.0,"total_display":"2,990.00","total_whole":"2,990","shares_owned_after":216347.0,"shares_owned_after_display":"216,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":2509285,"accession":"0001562180-24-006378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-006378","line_url":"/filing/0001562180-24-006378#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3173.0,"shares_display":"3,173","price_per_share":7.88,"price_display":"7.88","price_state":"stated","total_value":25003.24,"total_display":"25,003.24","total_whole":"25,003","shares_owned_after":97635.0,"shares_owned_after_display":"97,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider"},{"id":2186799,"accession":"0001562180-24-000636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-000636","line_url":"/filing/0001562180-24-000636#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (Executive Vice Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29956.0,"shares_display":"29,956","price_per_share":24.9783,"price_display":"24.98","price_state":"stated","total_value":748249.9548,"total_display":"748,249.95","total_whole":"748,250","shares_owned_after":135441.0,"shares_owned_after_display":"135,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-25","scope":"insider"},{"id":2186796,"accession":"0001562180-24-000636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-000636","line_url":"/filing/0001562180-24-000636#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (Executive Vice Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5044.0,"shares_display":"5,044","price_per_share":24.9702,"price_display":"24.97","price_state":"stated","total_value":125949.6888,"total_display":"125,949.69","total_whole":"125,950","shares_owned_after":165397.0,"shares_owned_after_display":"165,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider"},{"id":7879710,"accession":"0001562180-23-008170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-008170","line_url":"/filing/0001562180-23-008170#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (Executive Vice Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":20.76,"price_display":"20.76","price_state":"stated","total_value":415200.0,"total_display":"415,200.00","total_whole":"415,200","shares_owned_after":170559.0,"shares_owned_after_display":"170,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":4265274,"accession":"0001562180-21-007116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-007116","line_url":"/filing/0001562180-21-007116#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.148,"price_display":"20.15","price_state":"stated","total_value":201480.0,"total_display":"201,480.00","total_whole":"201,480","shares_owned_after":103546.0,"shares_owned_after_display":"103,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":3028462,"accession":"0001562180-20-002379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-002379","line_url":"/filing/0001562180-20-002379#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":98000.0,"shares_display":"98,000","price_per_share":1.0615,"price_display":"1.06","price_state":"stated","total_value":104027.0,"total_display":"104,027.00","total_whole":"104,027","shares_owned_after":574800.0,"shares_owned_after_display":"574,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-11","scope":"insider"},{"id":7902910,"accession":"0001562180-19-002055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-002055","line_url":"/filing/0001562180-19-002055#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28500.0,"shares_display":"28,500","price_per_share":1.763,"price_display":"1.76","price_state":"stated","total_value":50245.5,"total_display":"50,245.50","total_whole":"50,246","shares_owned_after":240200.0,"shares_owned_after_display":"240,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-04-01","scope":"insider"},{"id":4523825,"accession":"0000899243-17-016365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-016365","line_url":"/filing/0000899243-17-016365#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"pSivida Corp.","issuer_ticker":"PSDV","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56700.0,"shares_display":"56,700","price_per_share":1.763,"price_display":"1.76","price_state":"stated","total_value":99962.1,"total_display":"99,962.10","total_whole":"99,962","shares_owned_after":56700.0,"shares_owned_after_display":"56,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-14","scope":"insider"},{"id":6915495,"accession":"0001209191-14-073639","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-073639","line_url":"/filing/0001209191-14-073639","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32430.0,"shares_display":"32,430","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":1102620.0,"total_display":"1,102,620.00","total_whole":"1,102,620","shares_owned_after":17430.0,"shares_owned_after_display":"17,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-05","filed_date":"2014-12-08","scope":"insider","n_lines":2},{"id":6321004,"accession":"0001140361-14-041126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-041126","line_url":"/filing/0001140361-14-041126#line-2","is_derivative":false,"issuer_cik":"0001054102","issuer_name":"PDI INC","issuer_ticker":"PDII","issuer_name_source":null,"issuer_url":"/issuer/0001054102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":1.6931,"price_display":"1.69","price_state":"stated","total_value":27089.6,"total_display":"27,089.60","total_whole":"27,090","shares_owned_after":533317.0,"shares_owned_after_display":"533,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider"},{"id":6320999,"accession":"0001140361-14-041126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-041126","line_url":"/filing/0001140361-14-041126#line-1","is_derivative":false,"issuer_cik":"0001054102","issuer_name":"PDI INC","issuer_ticker":"PDII","issuer_name_source":null,"issuer_url":"/issuer/0001054102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33000.0,"shares_display":"33,000","price_per_share":1.7728,"price_display":"1.77","price_state":"stated","total_value":58502.4,"total_display":"58,502.40","total_whole":"58,502","shares_owned_after":517317.0,"shares_owned_after_display":"517,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2014-11-12","scope":"insider"},{"id":6377947,"accession":"0001140361-14-040591","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-14-040591","line_url":"/filing/0001140361-14-040591#line-5","is_derivative":false,"issuer_cik":"0001054102","issuer_name":"PDI INC","issuer_ticker":"PDII","issuer_name_source":null,"issuer_url":"/issuer/0001054102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":1600.0,"total_display":"1,600.00","total_whole":"1,600","shares_owned_after":490403.0,"shares_owned_after_display":"490,403","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-06","filed_date":"2014-11-07","scope":"insider"},{"id":6377943,"accession":"0001140361-14-040591","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-14-040591","line_url":"/filing/0001140361-14-040591","is_derivative":false,"issuer_cik":"0001054102","issuer_name":"PDI INC","issuer_ticker":"PDII","issuer_name_source":null,"issuer_url":"/issuer/0001054102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56000.0,"shares_display":"56,000","price_per_share":1.7417044642857142,"price_display":"1.74","price_state":"stated","total_value":97535.45,"total_display":"97,535.45","total_whole":"97,535","shares_owned_after":488403.0,"shares_owned_after_display":"488,403","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-05","filed_date":"2014-11-07","scope":"insider","n_lines":4},{"id":5653616,"accession":"0001140361-09-019257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-019257","line_url":"/filing/0001140361-09-019257#line-2","is_derivative":false,"issuer_cik":"0001054102","issuer_name":"PDI INC","issuer_ticker":"PDII","issuer_name_source":null,"issuer_url":"/issuer/0001054102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Officer (CEO)","role_mark":"O","role_mark_label":"Officer (CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":5.1731,"price_display":"5.17","price_state":"stated","total_value":31038.6,"total_display":"31,038.60","total_whole":"31,039","shares_owned_after":149960.0,"shares_owned_after_display":"149,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-18","filed_date":"2009-08-18","scope":"insider"},{"id":5653615,"accession":"0001140361-09-019257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-019257","line_url":"/filing/0001140361-09-019257#line-1","is_derivative":false,"issuer_cik":"0001054102","issuer_name":"PDI INC","issuer_ticker":"PDII","issuer_name_source":null,"issuer_url":"/issuer/0001054102","owner_cik":"0001450485","owner_name":"Lurker Nancy","owner_display_name":"Lurker Nancy","owner_url":"/insider/0001450485","role":"Officer (CEO)","role_mark":"O","role_mark_label":"Officer (CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3960.0,"shares_display":"3,960","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":19998.0,"total_display":"19,998.00","total_whole":"19,998","shares_owned_after":143960.0,"shares_owned_after_display":"143,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-17","filed_date":"2009-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Director","n_filings":1,"first_seen":"2026-05-15","last_seen":"2026-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint Pharmaceuticals, Inc.","url":"/issuer/0001314102","role":"Director, Officer (Executive Vice Chair)","n_filings":9,"first_seen":"2017-06-14","last_seen":"2025-12-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Director","n_filings":1,"first_seen":"2014-12-08","last_seen":"2014-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001054102","name":"PDI INC","url":"/issuer/0001054102","role":"Director, Officer (CEO)","n_filings":3,"first_seen":"2009-08-18","last_seen":"2014-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001450485","retrieved_at":"2026-08-24T09:05:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}